Skip to content
TrialScanner

NCT06099184

Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)

Phase 2CompletedEYPTLead

Registry record

Lead sponsor
EyePoint Pharmaceuticals, Inc.
Conditions
Diabetic Macular Edema
Primary completion
Oct 24, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06099184 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.